Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
Manoj Kumar Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo
Topics & Concepts
SemaglutideMedicineType 2 diabetesGlucagon-like peptide 1 receptorAdverse effectDiabetes mellitusAgonistPopulationInternal medicinePharmacologyHypoglycemiaDrugPharmacotherapyEndocrinologyPharmacistDulaglutideGlucagon-like peptide-1Weight lossGlucagonClinical trialGlucagon receptorExenatideDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsBariatric Surgery and Outcomes